Comparative Fasting Bioavailability of 2 Cilostazol Formulations in Healthy Thai Volunteers: An Open-Label, Single-Dose, Randomized, 2-Way Crossover Study.

Name: Work Video:
Duration: 3 min 30 s
Pinpilai Jutasompakorn; Supornchai Kongpatanakul; Piyapat Pongnarin; Korbtham Sathirakul; Somruedee Chatsiricharoenkul
{'id': 'https://openalex.org/W2218342685', 'doi': None, 'title': 'Comparative Fasting Bioavailability of 2 Cilostazol Formulations in Healthy Thai Volunteers: An Open-Label, Single-Dose, Randomized, 2-Way Crossover Study.', 'display_name': 'Comparative Fasting Bioavailability of 2 Cilostazol Formulations in Healthy Thai Volunteers: An Open-Label, Single-Dose, Randomized, 2-Way Crossover Study.', 'publication_year': 2015, 'publication_date': '2015-09-01', 'ids': {'openalex': 'https://openalex.org/W2218342685', 'mag': '2218342685', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/26591403'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26591403', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5077942601', 'display_name': 'Pinpilai Jutasompakorn', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Pinpilai Jutasompakorn', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039789898', 'display_name': 'Supornchai Kongpatanakul', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Supornchai Kongpatanakul', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083457696', 'display_name': 'Piyapat Pongnarin', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Piyapat Pongnarin', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055158425', 'display_name': 'Korbtham Sathirakul', 'orcid': 'https://orcid.org/0000-0003-1276-9266'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Korbtham Sathirakul', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5078028925', 'display_name': 'Somruedee Chatsiricharoenkul', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Somruedee Chatsiricharoenkul', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 66}, 'biblio': {'volume': '98', 'issue': '9', 'first_page': '910', 'last_page': '5'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11064', 'display_name': 'Antiplatelet Therapy and Cardiovascular Diseases', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/2705', 'display_name': 'Cardiology and Cardiovascular Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11460', 'display_name': 'Analytical Methods in Pharmaceuticals', 'score': 0.9926, 'subfield': {'id': 'https://openalex.org/subfields/1602', 'display_name': 'Analytical Chemistry'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T10678', 'display_name': 'Inflammatory mediators and NSAID effects', 'score': 0.9889, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/cilostazol', 'display_name': 'Cilostazol', 'score': 0.9740715}, {'id': 'https://openalex.org/keywords/bioequivalence', 'display_name': 'Bioequivalence', 'score': 0.88520896}, {'id': 'https://openalex.org/keywords/crossover-study', 'display_name': 'Crossover study', 'score': 0.75279605}, {'id': 'https://openalex.org/keywords/volunteer', 'display_name': 'Volunteer', 'score': 0.6164931}, {'id': 'https://openalex.org/keywords/fixed-dose-combination', 'display_name': 'Fixed-dose combination', 'score': 0.4346989}], 'concepts': [{'id': 'https://openalex.org/C2779820409', 'wikidata': 'https://www.wikidata.org/wiki/Q258591', 'display_name': 'Cilostazol', 'level': 3, 'score': 0.9740715}, {'id': 'https://openalex.org/C42404028', 'wikidata': 'https://www.wikidata.org/wiki/Q864940', 'display_name': 'Bioequivalence', 'level': 3, 'score': 0.88520896}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8361403}, {'id': 'https://openalex.org/C87813604', 'wikidata': 'https://www.wikidata.org/wiki/Q1242899', 'display_name': 'Crossover study', 'level': 4, 'score': 0.75279605}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.7381569}, {'id': 'https://openalex.org/C22979827', 'wikidata': 'https://www.wikidata.org/wiki/Q5137311', 'display_name': 'Cmax', 'level': 3, 'score': 0.6596675}, {'id': 'https://openalex.org/C2776768635', 'wikidata': 'https://www.wikidata.org/wiki/Q3427301', 'display_name': 'Volunteer', 'level': 2, 'score': 0.6164931}, {'id': 'https://openalex.org/C2777288759', 'wikidata': 'https://www.wikidata.org/wiki/Q4164182', 'display_name': 'Dosing', 'level': 2, 'score': 0.54994464}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.5302987}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.502794}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.47009513}, {'id': 'https://openalex.org/C3018023364', 'wikidata': 'https://www.wikidata.org/wiki/Q425265', 'display_name': 'Significant difference', 'level': 2, 'score': 0.44629958}, {'id': 'https://openalex.org/C2776623344', 'wikidata': 'https://www.wikidata.org/wiki/Q5456317', 'display_name': 'Fixed-dose combination', 'level': 2, 'score': 0.4346989}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.22116056}, {'id': 'https://openalex.org/C2777628954', 'wikidata': 'https://www.wikidata.org/wiki/Q18216', 'display_name': 'Aspirin', 'level': 2, 'score': 0.10548806}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.089827806}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C6557445', 'wikidata': 'https://www.wikidata.org/wiki/Q173113', 'display_name': 'Agronomy', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D005215', 'descriptor_name': 'Fasting', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D058987', 'descriptor_name': 'Phosphodiesterase 3 Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D013777', 'descriptor_name': 'Tetrazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D002626', 'descriptor_name': 'Chemistry, Pharmaceutical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002853', 'descriptor_name': 'Chromatography, Liquid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077407', 'descriptor_name': 'Cilostazol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018592', 'descriptor_name': 'Cross-Over Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D058987', 'descriptor_name': 'Phosphodiesterase 3 Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053719', 'descriptor_name': 'Tandem Mass Spectrometry', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013777', 'descriptor_name': 'Tetrazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013785', 'descriptor_name': 'Thailand', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013810', 'descriptor_name': 'Therapeutic Equivalency', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/26591403', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.66, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 10, 'referenced_works': ['https://openalex.org/W1997718908', 'https://openalex.org/W2000104976', 'https://openalex.org/W2028239587', 'https://openalex.org/W2029119494', 'https://openalex.org/W2047320782', 'https://openalex.org/W2047644852', 'https://openalex.org/W2077405191', 'https://openalex.org/W2099884864', 'https://openalex.org/W2100255765', 'https://openalex.org/W2163119611'], 'related_works': ['https://openalex.org/W2389356338', 'https://openalex.org/W2376335381', 'https://openalex.org/W2372787074', 'https://openalex.org/W2365294569', 'https://openalex.org/W2364542266', 'https://openalex.org/W2363093019', 'https://openalex.org/W2359939078', 'https://openalex.org/W2355880357', 'https://openalex.org/W2351830309', 'https://openalex.org/W2088936000'], 'abstract_inverted_index': {'To': [0], 'evaluate': [1], 'the': [2, 73, 83, 108, 117, 125, 131], 'bioequivalence': [3], 'of50': [4], 'mg': [5, 35, 135], 'cilostazol': [6, 36, 87, 136, 146], 'tablets': [7], 'manufactured': [8], 'locally': [9], '(Citazol®)': [10], 'and': [11, 51, 97], 'originally': [12], '(Pletaal®)': [13], 'in': [14, 26, 124], 'healthy': [15, 28], 'Thai': [16], 'volunteers.An': [17], 'open-label,': [18], 'single': [19], 'dose,': [20], 'randomized,': [21], 'two-period,': [22], 'two-sequence,': [23], 'crossover': [24], 'study': [25], '30': [27, 70], 'volunteers.': [29], 'Each': [30], 'volunteer': [31], 'received': [32], 'a': [33, 41], '50': [34, 134], 'tablet': [37, 147], 'of': [38, 86, 133], 'bothformulations': [39], 'with': [40, 65], 'washoutperiodofat': [42], 'least': [43], '14': [44], 'days.': [45], 'Blood': [46], 'samples': [47], 'were': [48, 59, 88, 120, 149], 'obtained': [49], 'atpre-dose': [50], 'over': [52], '48': [53], 'hours': [54], 'after': [55], 'dosing.': [56], 'Cilostazolplasma': [57], 'concentrations': [58], 'quantified': [60], 'by': [61], 'using': [62], 'liquid': [63], 'chromatography': [64], 'tandem': [66], 'mass': [67], 'spectrometry': [68], '(LC-MS/MS).The': [69], 'volunteers': [71], 'completed': [72], 'entire': [74], 'study.': [75], 'The': [76], 'geometric': [77], 'mean': [78], 'ratios': [79], '(GAM)': [80], '(test/reference)': [81], 'between': [82, 107, 130], 'two': [84, 145], 'formulations': [85, 148], '112.38%': [89], '(101.70%-124.19%)': [90], 'for': [91, 95], 'Cmax;': [92], '103.66%': [93], '(96.06%-111.86%)': [94], 'AUC0-48;': [96], '95.14%': [98], '(86.12%-105.12%)forAUC0-∞.': [99], 'There': [100], 'was': [101, 128], 'no': [102], 'statistical': [103], 'difference': [104, 123], 'ofthe': [105], 'Tmax': [106], 'twoformulations': [109, 132], '(p>0.05).': [110], 'No': [111], 'serious': [112], 'adverse': [113], 'events': [114], 'related': [115], 'to': [116], 'studied': [118], 'drugs': [119], 'found.No': [121], 'significant': [122], 'analyzed': [126], 'pharmacokineticparameters': [127], 'found': [129], 'tablets.': [137], 'Therefore,': [138], 'it': [139], 'can': [140], 'be': [141], 'concluded': [142], 'that': [143], 'these': [144], 'considered': [150], 'bioequivalent.': [151]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2218342685', 'counts_by_year': [], 'updated_date': '2024-12-07T01:25:13.391046', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
